Clinical Trials Browser

Waldenstrom Macroglobulinemia × Bortezomib × 1 year × Clear all

NCT00492050 2026-03-11

Bortezomib and Rituximab for Patients With Waldenstrom's Macroglobulinemia

Phase 2 Active not recruiting

46 enrolled 10 charts

Waldenstrom Macroglobulinemia

NCT02844322 2026-02-11

BDH-WM01

Phase 4 Completed

Waldenstrom Macroglobulinemia

NCT03620903 2025-12-05

Efficacy of First Line B-RI for Treatment Naive Waldenström's Macroglobulinemia

Phase 2 Active not recruiting

Waldenstrom Macroglobulinemia